Cargando…
Liraglutide Inhibits Osteoclastogenesis and Improves Bone Loss by Downregulating Trem2 in Female Type 1 Diabetic Mice: Findings From Transcriptomics
BACKGROUND: The mechanisms of bone fragility in type 1 diabetes (T1D) are not fully understood. Whether glucagon-like peptide-1 receptor (GLP-1R) agonists could improve bone quality in T1D context also remains elusive. AIMS: We aimed to explore the possible mechanisms of bone loss in T1D and clarify...
Autores principales: | Yu, Jie, Shi, Yan-Chuan, Ping, Fan, Li, Wei, Zhang, Hua-Bing, He, Shu-Li, Zhao, Yuan, Xu, Ling-Ling, Li, Yu-Xiu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8715718/ https://www.ncbi.nlm.nih.gov/pubmed/34975749 http://dx.doi.org/10.3389/fendo.2021.763646 |
Ejemplares similares
-
Gallic acid inhibits osteoclastogenesis and prevents ovariectomy-induced bone loss
por: Zhang, Peng, et al.
Publicado: (2022) -
Adiponectin Deficiency Triggers Bone Loss by Up-Regulation of Osteoclastogenesis and Down-Regulation of Osteoblastogenesis
por: Yang, Jihyun, et al.
Publicado: (2019) -
The Effect of Liraglutide on Weight Loss in Women with Polycystic Ovary Syndrome: An Observational Study
por: Rasmussen, Christina B., et al.
Publicado: (2014) -
Effect of glycosphingolipids on osteoclastogenesis and osteolytic bone diseases
por: Ersek, Adel, et al.
Publicado: (2012) -
Effect of metformin versus metformin plus liraglutide on gonadal and metabolic profiles in overweight patients with polycystic ovary syndrome
por: Xing, Chuan, et al.
Publicado: (2022)